TY - JOUR
T1 - Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis
AU - Cohen, Haim Y.
AU - Lavu, Siva
AU - Bitterman, Kevin J.
AU - Hekking, Brian
AU - Imahiyerobo, Thomas A.
AU - Miller, Christine
AU - Frye, Roy
AU - Ploegh, Hidde
AU - Kessler, Benedikt M.
AU - Sinclair, David A.
N1 - Funding Information:
We thank members of the Sinclair lab, G. Gill, A. Brunet, M. Oettinger, B. Affar, N. Wall, L. Williams, Y. Dai, R. Hache, S. Matsuyama, G. Li, S. Luikenhuis, and D. Thanos for reagents and manuscript preparation. This work was supported by NIH/NIA grants GM068072 and AG19719-03 and the Leukemia and Lymphoma Society of America. D.A.S. is an Ellison Medical Research Foundation Special Fellow. H.Y.C. is an Ellison/American Federation of Aging Research Senior Postdoctoral Fellow. K.J.B. is a Harvard MPM Scholar. B.M.K. is a multiple Myeloma Research Foundation Senior Research Fellow.
PY - 2004/3/5
Y1 - 2004/3/5
N2 - Apoptosis is a key tumor suppression mechanism that can be initiated by activation of the proapoptotic factor Bax. The Ku70 DNA end-joining protein has recently been shown to suppress apoptosis by sequestering Bax from mitochondria. The mechanism by which Bax is regulated remains unknown. Here, we identify eight lysines in Ku70 that are targets for acetylation in vivo. Five of these, K539, K542, K544, K533, and K556, lie in the C-terminal linker domain of Ku70 adjacent to the Bax interaction domain. We show that CBP and PCAF efficiently acetylate K542 in vitro and associate with Ku70 in vivo. Mimicking acetylation of K539 or K542 or treating cells with deacetylase inhibitors abolishes the ability of Ku70 to suppress Bax-mediated apoptosis. We demonstrate that increased acetylation of Ku70 disrupts the Ku70-Bax interaction and coincides with cytoplasmic accumulation of CBP. These results shed light on the role of acetyltransferases as tumor suppressors.
AB - Apoptosis is a key tumor suppression mechanism that can be initiated by activation of the proapoptotic factor Bax. The Ku70 DNA end-joining protein has recently been shown to suppress apoptosis by sequestering Bax from mitochondria. The mechanism by which Bax is regulated remains unknown. Here, we identify eight lysines in Ku70 that are targets for acetylation in vivo. Five of these, K539, K542, K544, K533, and K556, lie in the C-terminal linker domain of Ku70 adjacent to the Bax interaction domain. We show that CBP and PCAF efficiently acetylate K542 in vitro and associate with Ku70 in vivo. Mimicking acetylation of K539 or K542 or treating cells with deacetylase inhibitors abolishes the ability of Ku70 to suppress Bax-mediated apoptosis. We demonstrate that increased acetylation of Ku70 disrupts the Ku70-Bax interaction and coincides with cytoplasmic accumulation of CBP. These results shed light on the role of acetyltransferases as tumor suppressors.
UR - http://www.scopus.com/inward/record.url?scp=12144286529&partnerID=8YFLogxK
U2 - 10.1016/S1097-2765(04)00094-2
DO - 10.1016/S1097-2765(04)00094-2
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 15023334
AN - SCOPUS:12144286529
SN - 1097-2765
VL - 13
SP - 627
EP - 638
JO - Molecular Cell
JF - Molecular Cell
IS - 5
ER -